Results 181 to 190 of about 23,621 (250)

YAP1 and QSER1 are key modulators of embryonic signaling pathways in the mammalian epiblast. [PDF]

EMBO Rep
Abraham E, Roule T, Douglas A, Megill E, Pericak OM, Howe JE, Choya-Foces C, Garbincius JF, Cohen HM, Roig-Flórez P, Zubillaga M, Andrake MD, Kim S, Elrod JW, Akizu N, Estaras C.   +15 more
europepmc   +1 more source

Comprehensive metabolic characterization of pediatric ependymomas. [PDF]

Life Metab
Li T, Jin Y, Ren S, Liu Y, Cheng D, Bi Z, Li Y, Chen X, Zhu X, Chen Z, He W, Li Y, Liu Y, Luan G, Tian Y, Liu Y, Ge WP.   +16 more
europepmc   +1 more source

Primary Cilium Forces Neuroendocrine Shift in Prostate Cancer through YAP1 Repression and Reduced Mitochondrial Activity. [PDF]

Theranostics
Guo Y, Peng S, Jamet T, Firlej V, Irondelle M, Nau C, Girard CA, Asrani K, Lotan TL, Huc R, Soyeux P, Rouleau M, Lacas-Gervais S, Rovini A, Luciano S, Humbert O, Schiappa R, Pujalte-Martin M, Vigneau M, Peraldi P, Bost F, Lazennec G, Vacherot F, Mazure NM.   +23 more
europepmc   +1 more source

Inhibition of circZFX suppresses malignant phenotypes in cholangiocarcinoma via the miR-654-3p/HDGF and YAP1 signaling activation. [PDF]

Biol Direct
Liang T, Gong C, Yang X, Shen J, Jiang G, Liu J, Yang G, Guo L.   +7 more
europepmc   +1 more source

CDH4/UBA1/RBMX axis promotes polycystic ovary syndrome progression through YAP1 activation. [PDF]

Cell Mol Biol Lett
Xu N, Yu B, Li Y, Yang Y, Wang Y, Fang L, Wu H, Luan Y, Yin C.   +8 more
europepmc   +1 more source

The hippo-YAP1/TEAD1-SLC7A5 axis: uncovering a novel therapeutic target for oxalate-induced renal tubular ferroptosis. [PDF]

Redox Rep
Yang J, Ma Z, Wan W, Yuan D, Li J, Wang Y, Wang B, Lyu G, Xun Y, Yu X.   +9 more
europepmc   +1 more source

SAMD4 represses VGLL4 mRNA to activate TEAD and promote cancer progression. [PDF]

Oncogene
Otani J, Nishio M, Tokita R, Hikasa H, Nishimori M, Dan S, Naguro I, Ichijo H, Miyanishi M, Sasaki T, Nishina H, Mak TW, Maehama T, Suzuki A.   +13 more
europepmc   +1 more source

Targeting the Hippo pathway in pulmonary arterial hypertension: emerging pharmacological strategies. [PDF]

J Hypertens
Zheng D, Guo Y.
europepmc   +1 more source

LncRNA MCM3AP-AS1 is a potential prognostic marker for osteosarcoma and promotes its development by targeting miR-205-5p. [PDF]

Discov Oncol
Liu Y, Wang M, Wang GG, Huang LN, Chen W.   +4 more
europepmc   +1 more source

PIK3CA mutant cervical cancer is selectively suppressed by PI3Kα inhibition (Alpelisib/BYL-719 and Inavolisib/GDC-0077) and cooperates with HPV directed T cell therapy. [PDF]

Neoplasia
Lou H, Langan D, Syracuse N, Murphy EA, Kim S, Robinson E, Rossi NM, Xie Y, Tulsyan S, Joe T, Rodriguez I, Rao N, Oberley MR, Oelke M, Dean M.   +14 more
europepmc   +1 more source